

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | actin-myosin filament sliding (GO:0033275) | 5.16628473 |
| 2 | muscle filament sliding (GO:0030049) | 5.16628473 |
| 3 | sarcomere organization (GO:0045214) | 5.07605075 |
| 4 | plasma membrane repair (GO:0001778) | 5.06465772 |
| 5 | regulation of skeletal muscle contraction (GO:0014819) | 5.03337582 |
| 6 | cardiac myofibril assembly (GO:0055003) | 4.65232224 |
| 7 | myofibril assembly (GO:0030239) | 4.56235787 |
| 8 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.43179987 |
| 9 | actin-mediated cell contraction (GO:0070252) | 4.39567535 |
| 10 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.26888427 |
| 11 | barbed-end actin filament capping (GO:0051016) | 4.18334672 |
| 12 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.12461402 |
| 13 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 4.05042294 |
| 14 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 4.04925906 |
| 15 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.99591426 |
| 16 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.86076954 |
| 17 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 3.76086962 |
| 18 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 3.72876551 |
| 19 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.72863103 |
| 20 | actomyosin structure organization (GO:0031032) | 3.70312609 |
| 21 | cardiac muscle contraction (GO:0060048) | 3.69911053 |
| 22 | semaphorin-plexin signaling pathway (GO:0071526) | 3.68828322 |
| 23 | protein localization to endosome (GO:0036010) | 3.59794224 |
| 24 | striated muscle contraction (GO:0006941) | 3.52645277 |
| 25 | actin filament-based movement (GO:0030048) | 3.51290137 |
| 26 | skeletal muscle contraction (GO:0003009) | 3.49530545 |
| 27 | skin morphogenesis (GO:0043589) | 3.42956681 |
| 28 | regulation of membrane repolarization (GO:0060306) | 3.41926525 |
| 29 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.34923172 |
| 30 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 3.34861499 |
| 31 | creatine metabolic process (GO:0006600) | 3.34686779 |
| 32 | regulation of actin filament-based movement (GO:1903115) | 3.34431883 |
| 33 | cardiac muscle cell development (GO:0055013) | 3.33101997 |
| 34 | adherens junction assembly (GO:0034333) | 3.30905213 |
| 35 | epithelial cell-cell adhesion (GO:0090136) | 3.21103118 |
| 36 | adult heart development (GO:0007512) | 3.20874805 |
| 37 | regulation of cell communication by electrical coupling (GO:0010649) | 3.20548205 |
| 38 | Golgi transport vesicle coating (GO:0048200) | 3.19797991 |
| 39 | COPI coating of Golgi vesicle (GO:0048205) | 3.19797991 |
| 40 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.17673419 |
| 41 | cardiac cell development (GO:0055006) | 3.17260443 |
| 42 | positive regulation of receptor recycling (GO:0001921) | 3.17245795 |
| 43 | cell-cell junction maintenance (GO:0045217) | 3.14981258 |
| 44 | focal adhesion assembly (GO:0048041) | 3.13022997 |
| 45 | cell-substrate adherens junction assembly (GO:0007045) | 3.13022997 |
| 46 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 3.11522526 |
| 47 | negative regulation of protein localization to cell surface (GO:2000009) | 3.10080501 |
| 48 | cell communication by electrical coupling (GO:0010644) | 3.08900778 |
| 49 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.07875612 |
| 50 | regulation of relaxation of muscle (GO:1901077) | 3.04778154 |
| 51 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.98708896 |
| 52 | stress fiber assembly (GO:0043149) | 2.98053422 |
| 53 | regulation of striated muscle contraction (GO:0006942) | 2.97310968 |
| 54 | skeletal muscle adaptation (GO:0043501) | 2.97295070 |
| 55 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.95459861 |
| 56 | cell-substrate junction assembly (GO:0007044) | 2.94167442 |
| 57 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.92555711 |
| 58 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.92555711 |
| 59 | protein retention in ER lumen (GO:0006621) | 2.89220179 |
| 60 | regulation of skeletal muscle cell differentiation (GO:2001014) | 2.88985685 |
| 61 | heart trabecula formation (GO:0060347) | 2.87430228 |
| 62 | endothelial cell chemotaxis (GO:0035767) | 2.87299073 |
| 63 | regulation of p38MAPK cascade (GO:1900744) | 2.86872645 |
| 64 | apoptotic cell clearance (GO:0043277) | 2.86858045 |
| 65 | regulation of early endosome to late endosome transport (GO:2000641) | 2.86744634 |
| 66 | positive regulation of extracellular matrix organization (GO:1903055) | 2.85666483 |
| 67 | basement membrane organization (GO:0071711) | 2.85468117 |
| 68 | muscle contraction (GO:0006936) | 2.85227472 |
| 69 | cell communication involved in cardiac conduction (GO:0086065) | 2.83255713 |
| 70 | regulation of extracellular matrix disassembly (GO:0010715) | 2.80329848 |
| 71 | neuromuscular junction development (GO:0007528) | 2.77447172 |
| 72 | positive regulation of cation channel activity (GO:2001259) | 2.71945322 |
| 73 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.71696637 |
| 74 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.71571694 |
| 75 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.71134120 |
| 76 | cardiac muscle tissue morphogenesis (GO:0055008) | 2.70229837 |
| 77 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.69608743 |
| 78 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.68564395 |
| 79 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.67445304 |
| 80 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.67282694 |
| 81 | axonemal dynein complex assembly (GO:0070286) | 2.66565009 |
| 82 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.64630713 |
| 83 | potassium ion import (GO:0010107) | 2.63308316 |
| 84 | response to inactivity (GO:0014854) | 2.62549096 |
| 85 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.62207140 |
| 86 | muscle tissue morphogenesis (GO:0060415) | 2.62016529 |
| 87 | cardiac muscle hypertrophy (GO:0003300) | 2.60439999 |
| 88 | striated muscle hypertrophy (GO:0014897) | 2.59916375 |
| 89 | muscle system process (GO:0003012) | 2.58688460 |
| 90 | carnitine shuttle (GO:0006853) | 2.58565699 |
| 91 | negative regulation of fatty acid transport (GO:2000192) | 2.57762909 |
| 92 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.54831455 |
| 93 | Wnt signaling pathway, planar cell polarity pathway (GO:0060071) | 2.54473814 |
| 94 | embryo implantation (GO:0007566) | 2.52889485 |
| 95 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.52677880 |
| 96 | regulation of sarcomere organization (GO:0060297) | 2.52203003 |
| 97 | maternal placenta development (GO:0001893) | 2.51964213 |
| 98 | muscle cell cellular homeostasis (GO:0046716) | 2.49242074 |
| 99 | motile cilium assembly (GO:0044458) | 2.47704019 |
| 100 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.46667777 |
| 101 | tooth mineralization (GO:0034505) | 2.46537232 |
| 102 | camera-type eye morphogenesis (GO:0048593) | 2.46324798 |
| 103 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.43854454 |
| 104 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.43309892 |
| 105 | regulation of synapse structural plasticity (GO:0051823) | 2.43146568 |
| 106 | protein heterotrimerization (GO:0070208) | 2.42540416 |
| 107 | hemidesmosome assembly (GO:0031581) | 2.42504957 |
| 108 | negative regulation of potassium ion transport (GO:0043267) | 2.41870173 |
| 109 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 2.41240673 |
| 110 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.41143064 |
| 111 | striated muscle adaptation (GO:0014888) | 2.41137549 |
| 112 | muscle fiber development (GO:0048747) | 2.41092939 |
| 113 | mannose metabolic process (GO:0006013) | 2.41081787 |
| 114 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.40966071 |
| 115 | desmosome organization (GO:0002934) | 2.40172655 |
| 116 | regulation of extracellular matrix organization (GO:1903053) | 2.39765538 |
| 117 | establishment of apical/basal cell polarity (GO:0035089) | 2.38039052 |
| 118 | cochlea morphogenesis (GO:0090103) | 2.37799872 |
| 119 | myoblast fusion (GO:0007520) | 2.37688765 |
| 120 | photoreceptor cell differentiation (GO:0046530) | 2.37406629 |
| 121 | eye photoreceptor cell differentiation (GO:0001754) | 2.37406629 |
| 122 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.37324953 |
| 123 | protein targeting to plasma membrane (GO:0072661) | 2.37165671 |
| 124 | cell junction maintenance (GO:0034331) | 2.36305203 |
| 125 | cardiac muscle cell action potential (GO:0086001) | 2.36103344 |
| 126 | actin filament bundle assembly (GO:0051017) | 2.35926480 |
| 127 | actin filament bundle organization (GO:0061572) | 2.35926480 |
| 128 | activation of Rac GTPase activity (GO:0032863) | 2.35465191 |
| 129 | syncytium formation by plasma membrane fusion (GO:0000768) | 2.35191921 |
| 130 | regulation of establishment of planar polarity (GO:0090175) | 2.34667583 |
| 131 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.34525834 |
| 132 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.34317214 |
| 133 | striated muscle cell development (GO:0055002) | 2.34296939 |
| 134 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.33938726 |
| 135 | endodermal cell differentiation (GO:0035987) | 2.33913805 |
| 136 | regulation of cardiac muscle contraction (GO:0055117) | 2.32922827 |
| 137 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 2.32592734 |
| 138 | regulation of potassium ion transmembrane transport (GO:1901379) | 2.32307645 |
| 139 | regulation of potassium ion transmembrane transporter activity (GO:1901016) | 2.32215156 |
| 140 | regulation of cation channel activity (GO:2001257) | 2.31484931 |
| 141 | amyloid precursor protein catabolic process (GO:0042987) | 2.31455356 |
| 142 | layer formation in cerebral cortex (GO:0021819) | 2.30303825 |
| 143 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.30185605 |
| 144 | positive regulation of protein dephosphorylation (GO:0035307) | 2.29700144 |
| 145 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.29308488 |
| 146 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.28942254 |
| 147 | substrate-dependent cell migration (GO:0006929) | 2.28801312 |
| 148 | membrane protein ectodomain proteolysis (GO:0006509) | 2.28456666 |
| 149 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.28408876 |
| 150 | negative regulation of catenin import into nucleus (GO:0035414) | 2.28394701 |
| 151 | hypotonic response (GO:0006971) | 2.28261907 |
| 152 | regulation of the force of heart contraction (GO:0002026) | 2.27085960 |
| 153 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.26437271 |
| 154 | positive regulation of ion transmembrane transporter activity (GO:0032414) | 2.26354145 |
| 155 | cell migration in hindbrain (GO:0021535) | 2.26035557 |
| 156 | apoptotic process involved in morphogenesis (GO:0060561) | 2.25885599 |
| 157 | regulation of heart rate by cardiac conduction (GO:0086091) | 2.25600040 |
| 158 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.25171057 |
| 159 | regulation of heart rate (GO:0002027) | 2.24659901 |
| 160 | coronary vasculature morphogenesis (GO:0060977) | 2.24080428 |
| 161 | cardiac conduction (GO:0061337) | 2.23924229 |
| 162 | activation of protein kinase A activity (GO:0034199) | 2.23433110 |
| 163 | regulation of heart contraction (GO:0008016) | 2.23162555 |
| 164 | cell migration involved in heart development (GO:0060973) | 2.22700191 |
| 165 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.22083839 |
| 166 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.21994607 |
| 167 | positive regulation of potassium ion transport (GO:0043268) | 2.21808047 |
| 168 | detection of calcium ion (GO:0005513) | 2.21720044 |
| 169 | negative regulation of cell size (GO:0045792) | 2.21711420 |
| 170 | cell volume homeostasis (GO:0006884) | 2.21361632 |
| 171 | muscle structure development (GO:0061061) | 2.20853708 |
| 172 | ear development (GO:0043583) | 2.20749970 |
| 173 | membrane tubulation (GO:0097320) | 2.19733904 |
| 174 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.19613662 |
| 175 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.19269976 |
| 176 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.18915127 |
| 177 | muscle organ development (GO:0007517) | 2.18841513 |
| 178 | chondroitin sulfate biosynthetic process (GO:0030206) | 2.17785270 |
| 179 | type B pancreatic cell proliferation (GO:0044342) | 2.17457010 |
| 180 | glial cell migration (GO:0008347) | 2.16793224 |
| 181 | kidney mesenchyme development (GO:0072074) | 2.16436957 |
| 182 | actin filament depolymerization (GO:0030042) | 2.15836424 |
| 183 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.14980297 |
| 184 | macroautophagy (GO:0016236) | 2.14254619 |
| 185 | amyloid precursor protein metabolic process (GO:0042982) | 2.13581533 |
| 186 | response to laminar fluid shear stress (GO:0034616) | 2.13339694 |
| 187 | Rho protein signal transduction (GO:0007266) | 2.13189051 |
| 188 | atrioventricular valve morphogenesis (GO:0003181) | 2.12422875 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.57260093 |
| 2 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.90010749 |
| 3 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.48528341 |
| 4 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.45915992 |
| 5 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.45915992 |
| 6 | RACK7_27058665_Chip-Seq_MCF-7_Human | 2.44842434 |
| 7 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.43594506 |
| 8 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.37213924 |
| 9 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.28948763 |
| 10 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.28892507 |
| 11 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.27219665 |
| 12 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.25955867 |
| 13 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.24958748 |
| 14 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.23958846 |
| 15 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.22835807 |
| 16 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 2.19469604 |
| 17 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.17964017 |
| 18 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.15480439 |
| 19 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.11071602 |
| 20 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.02677680 |
| 21 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.01324840 |
| 22 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.97754249 |
| 23 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.97742269 |
| 24 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.96828051 |
| 25 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.96577457 |
| 26 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.93889368 |
| 27 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.89760954 |
| 28 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.88394872 |
| 29 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.84500112 |
| 30 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.81790313 |
| 31 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.78760187 |
| 32 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.78074391 |
| 33 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.77236164 |
| 34 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.70949185 |
| 35 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.68236238 |
| 36 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.67145248 |
| 37 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.66373186 |
| 38 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.64529531 |
| 39 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.64529531 |
| 40 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.61489229 |
| 41 | KDM2B_26808549_Chip-Seq_K562_Human | 1.61181121 |
| 42 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.60487759 |
| 43 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.59587412 |
| 44 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.58771148 |
| 45 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.58189636 |
| 46 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.57050141 |
| 47 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.56510799 |
| 48 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.55186324 |
| 49 | * ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.52876718 |
| 50 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.49995964 |
| 51 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.45018508 |
| 52 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.43716114 |
| 53 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.43157839 |
| 54 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.40962658 |
| 55 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.39864222 |
| 56 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.38458992 |
| 57 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.36843937 |
| 58 | * OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.34514519 |
| 59 | * PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.32855223 |
| 60 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.31053115 |
| 61 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.30423264 |
| 62 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.30110887 |
| 63 | * TP53_22127205_ChIP-Seq_IMR90_Human | 1.28260305 |
| 64 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.27444345 |
| 65 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.27413574 |
| 66 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.26957852 |
| 67 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.24932652 |
| 68 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.24036578 |
| 69 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.23389722 |
| 70 | P68_20966046_ChIP-Seq_HELA_Human | 1.23349696 |
| 71 | * RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.22366638 |
| 72 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.21012036 |
| 73 | * SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.20673390 |
| 74 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.20544178 |
| 75 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.20340694 |
| 76 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.19449305 |
| 77 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.19448252 |
| 78 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.19354055 |
| 79 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.18312490 |
| 80 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.17635626 |
| 81 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.15999200 |
| 82 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.15902614 |
| 83 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.14741122 |
| 84 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.14491228 |
| 85 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.13425517 |
| 86 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.13001795 |
| 87 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.12838070 |
| 88 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.12740692 |
| 89 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.11679094 |
| 90 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.09990999 |
| 91 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.09876592 |
| 92 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.09727712 |
| 93 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.09430916 |
| 94 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.08493757 |
| 95 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.08467806 |
| 96 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.08455331 |
| 97 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.08442942 |
| 98 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.08040575 |
| 99 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.07233910 |
| 100 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.07045739 |
| 101 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.06934154 |
| 102 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.06392815 |
| 103 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.06081697 |
| 104 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.04111670 |
| 105 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.04078341 |
| 106 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.03856145 |
| 107 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.03694312 |
| 108 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.03235344 |
| 109 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.03199390 |
| 110 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.02213838 |
| 111 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.01624611 |
| 112 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.99400123 |
| 113 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.98696515 |
| 114 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 0.98203014 |
| 115 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.97783026 |
| 116 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.97636678 |
| 117 | AR_19668381_ChIP-Seq_PC3_Human | 0.97361556 |
| 118 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.95272095 |
| 119 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.94564557 |
| 120 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.94275480 |
| 121 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.93747385 |
| 122 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.93434180 |
| 123 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.93189413 |
| 124 | * NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.92985155 |
| 125 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.92972422 |
| 126 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.92731332 |
| 127 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.92295143 |
| 128 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.91799538 |
| 129 | * TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.90803605 |
| 130 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90784627 |
| 131 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.90289463 |
| 132 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.90278076 |
| 133 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.89941127 |
| 134 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.89029993 |
| 135 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.88820875 |
| 136 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.87340942 |
| 137 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.85918993 |
| 138 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.85262848 |
| 139 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.85012927 |
| 140 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.84444638 |
| 141 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.82814470 |
| 142 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.82623410 |
| 143 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.82208635 |
| 144 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.81981275 |
| 145 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.80197152 |
| 146 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.80073246 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000751_myopathy | 4.72403047 |
| 2 | MP0002837_dystrophic_cardiac_calcinosis | 4.48907505 |
| 3 | MP0004145_abnormal_muscle_electrophysio | 3.65609027 |
| 4 | MP0000749_muscle_degeneration | 3.51612232 |
| 5 | MP0003646_muscle_fatigue | 3.38800196 |
| 6 | MP0004084_abnormal_cardiac_muscle | 3.12780620 |
| 7 | MP0004036_abnormal_muscle_relaxation | 3.11039438 |
| 8 | MP0005058_abnormal_lysosome_morphology | 2.85425428 |
| 9 | MP0004215_abnormal_myocardial_fiber | 2.61236294 |
| 10 | MP0004087_abnormal_muscle_fiber | 2.42219302 |
| 11 | MP0005257_abnormal_intraocular_pressure | 2.39521188 |
| 12 | MP0002106_abnormal_muscle_physiology | 2.38427007 |
| 13 | MP0000750_abnormal_muscle_regeneration | 2.36784821 |
| 14 | MP0000747_muscle_weakness | 2.35699393 |
| 15 | MP0005330_cardiomyopathy | 2.24963616 |
| 16 | MP0003566_abnormal_cell_adhesion | 2.23758259 |
| 17 | MP0005620_abnormal_muscle_contractility | 2.22755423 |
| 18 | MP0000759_abnormal_skeletal_muscle | 2.20030175 |
| 19 | MP0005451_abnormal_body_composition | 2.16482595 |
| 20 | MP0002877_abnormal_melanocyte_morpholog | 2.13062229 |
| 21 | MP0005369_muscle_phenotype | 2.11361001 |
| 22 | MP0004233_abnormal_muscle_weight | 2.10073460 |
| 23 | MP0001849_ear_inflammation | 2.08003886 |
| 24 | MP0004130_abnormal_muscle_cell | 2.07694883 |
| 25 | MP0003137_abnormal_impulse_conducting | 2.00961208 |
| 26 | MP0003191_abnormal_cellular_cholesterol | 1.90279298 |
| 27 | MP0004510_myositis | 1.88199684 |
| 28 | MP0002269_muscular_atrophy | 1.87137830 |
| 29 | MP0003091_abnormal_cell_migration | 1.85642702 |
| 30 | MP0002972_abnormal_cardiac_muscle | 1.82622551 |
| 31 | MP0005076_abnormal_cell_differentiation | 1.81654942 |
| 32 | MP0002234_abnormal_pharynx_morphology | 1.79800996 |
| 33 | MP0005623_abnormal_meninges_morphology | 1.75854345 |
| 34 | MP0003283_abnormal_digestive_organ | 1.68902888 |
| 35 | MP0010234_abnormal_vibrissa_follicle | 1.68851201 |
| 36 | MP0008438_abnormal_cutaneous_collagen | 1.68684729 |
| 37 | MP0009780_abnormal_chondrocyte_physiolo | 1.68275854 |
| 38 | MP0009840_abnormal_foam_cell | 1.62079345 |
| 39 | MP0003950_abnormal_plasma_membrane | 1.59207287 |
| 40 | MP0003453_abnormal_keratinocyte_physiol | 1.59077123 |
| 41 | MP0010630_abnormal_cardiac_muscle | 1.56655984 |
| 42 | MP0002108_abnormal_muscle_morphology | 1.56326480 |
| 43 | MP0000733_abnormal_muscle_development | 1.54536607 |
| 44 | MP0000013_abnormal_adipose_tissue | 1.51865036 |
| 45 | MP0003329_amyloid_beta_deposits | 1.50960899 |
| 46 | MP0005023_abnormal_wound_healing | 1.50506894 |
| 47 | MP0005409_darkened_coat_color | 1.48254985 |
| 48 | MP0006072_abnormal_retinal_apoptosis | 1.47833036 |
| 49 | MP0004085_abnormal_heartbeat | 1.47647703 |
| 50 | MP0002249_abnormal_larynx_morphology | 1.44002127 |
| 51 | MP0008775_abnormal_heart_ventricle | 1.41111198 |
| 52 | MP0006138_congestive_heart_failure | 1.40851102 |
| 53 | MP0009384_cardiac_valve_regurgitation | 1.39952604 |
| 54 | MP0008260_abnormal_autophagy | 1.39849174 |
| 55 | MP0001544_abnormal_cardiovascular_syste | 1.39600450 |
| 56 | MP0005385_cardiovascular_system_phenoty | 1.39600450 |
| 57 | MP0004859_abnormal_synaptic_plasticity | 1.38287483 |
| 58 | MP0004484_altered_response_of | 1.38136675 |
| 59 | MP0008961_abnormal_basal_metabolism | 1.37839275 |
| 60 | MP0004270_analgesia | 1.37147159 |
| 61 | MP0000767_abnormal_smooth_muscle | 1.34241726 |
| 62 | MP0005248_abnormal_Harderian_gland | 1.33971643 |
| 63 | MP0003172_abnormal_lysosome_physiology | 1.33684195 |
| 64 | MP0005503_abnormal_tendon_morphology | 1.31774112 |
| 65 | MP0000003_abnormal_adipose_tissue | 1.26235235 |
| 66 | MP0005508_abnormal_skeleton_morphology | 1.24810459 |
| 67 | MP0002060_abnormal_skin_morphology | 1.22236924 |
| 68 | MP0001299_abnormal_eye_distance/ | 1.20651549 |
| 69 | MP0005375_adipose_tissue_phenotype | 1.17292364 |
| 70 | MP0003075_altered_response_to | 1.16211098 |
| 71 | MP0005275_abnormal_skin_tensile | 1.15129122 |
| 72 | MP0001542_abnormal_bone_strength | 1.15053807 |
| 73 | MP0005551_abnormal_eye_electrophysiolog | 1.11321431 |
| 74 | MP0000678_abnormal_parathyroid_gland | 1.10873532 |
| 75 | MP0002909_abnormal_adrenal_gland | 1.09646074 |
| 76 | MP0005666_abnormal_adipose_tissue | 1.09081734 |
| 77 | MP0003300_gastrointestinal_ulcer | 1.08005373 |
| 78 | MP0001348_abnormal_lacrimal_gland | 1.07054120 |
| 79 | MP0004272_abnormal_basement_membrane | 1.06670598 |
| 80 | MP0002089_abnormal_postnatal_growth/wei | 1.06544553 |
| 81 | MP0010030_abnormal_orbit_morphology | 1.05295028 |
| 82 | MP0008569_lethality_at_weaning | 1.04951682 |
| 83 | MP0000858_altered_metastatic_potential | 1.03327274 |
| 84 | MP0002998_abnormal_bone_remodeling | 1.03229987 |
| 85 | MP0003385_abnormal_body_wall | 1.02499918 |
| 86 | MP0004043_abnormal_pH_regulation | 1.01151468 |
| 87 | MP0004858_abnormal_nervous_system | 0.99521035 |
| 88 | MP0003279_aneurysm | 0.99120508 |
| 89 | MP0003690_abnormal_glial_cell | 0.98229600 |
| 90 | MP0000778_abnormal_nervous_system | 0.97811512 |
| 91 | MP0004185_abnormal_adipocyte_glucose | 0.96398596 |
| 92 | MP0005165_increased_susceptibility_to | 0.95664416 |
| 93 | MP0002653_abnormal_ependyma_morphology | 0.94920779 |
| 94 | MP0003635_abnormal_synaptic_transmissio | 0.94426039 |
| 95 | MP0003705_abnormal_hypodermis_morpholog | 0.93769352 |
| 96 | MP0005390_skeleton_phenotype | 0.91971026 |
| 97 | MP0002127_abnormal_cardiovascular_syste | 0.91623473 |
| 98 | MP0000343_altered_response_to | 0.88899741 |
| 99 | MP0009250_abnormal_appendicular_skeleto | 0.88092274 |
| 100 | MP0003303_peritoneal_inflammation | 0.85873438 |
| 101 | MP0001958_emphysema | 0.85746005 |
| 102 | MP0003879_abnormal_hair_cell | 0.85505952 |
| 103 | MP0001533_abnormal_skeleton_physiology | 0.84163049 |
| 104 | MP0005253_abnormal_eye_physiology | 0.84060052 |
| 105 | MP0000467_abnormal_esophagus_morphology | 0.83971202 |
| 106 | MP0005595_abnormal_vascular_smooth | 0.83479200 |
| 107 | MP0000534_abnormal_ureter_morphology | 0.83278041 |
| 108 | MP0002796_impaired_skin_barrier | 0.82808607 |
| 109 | MP0005083_abnormal_biliary_tract | 0.82748835 |
| 110 | MP0009278_abnormal_bone_marrow | 0.81916271 |
| 111 | MP0005423_abnormal_somatic_nervous | 0.81409546 |
| 112 | MP0003122_maternal_imprinting | 0.81408746 |
| 113 | MP0002332_abnormal_exercise_endurance | 0.79937298 |
| 114 | MP0000681_abnormal_thyroid_gland | 0.79559270 |
| 115 | MP0003828_pulmonary_edema | 0.79202907 |
| 116 | MP0005164_abnormal_response_to | 0.78880910 |
| 117 | MP0000604_amyloidosis | 0.77834202 |
| 118 | MP0009053_abnormal_anal_canal | 0.77618461 |
| 119 | MP0003634_abnormal_glial_cell | 0.76781968 |
| 120 | MP0000428_abnormal_craniofacial_morphol | 0.75241747 |
| 121 | MP0005670_abnormal_white_adipose | 0.74809714 |
| 122 | MP0001879_abnormal_lymphatic_vessel | 0.73484598 |
| 123 | MP0002896_abnormal_bone_mineralization | 0.72960439 |
| 124 | MP0001243_abnormal_dermal_layer | 0.72892454 |
| 125 | MP0000266_abnormal_heart_morphology | 0.71855388 |
| 126 | MP0002882_abnormal_neuron_morphology | 0.71205452 |
| 127 | MP0000955_abnormal_spinal_cord | 0.71128919 |
| 128 | MP0002113_abnormal_skeleton_development | 0.71072030 |
| 129 | MP0002295_abnormal_pulmonary_circulatio | 0.70676372 |
| 130 | MP0002932_abnormal_joint_morphology | 0.69258541 |
| 131 | MP0002272_abnormal_nervous_system | 0.69055978 |
| 132 | MP0000537_abnormal_urethra_morphology | 0.68901965 |
| 133 | MP0010368_abnormal_lymphatic_system | 0.68364995 |
| 134 | MP0004885_abnormal_endolymph | 0.68331050 |
| 135 | MP0000163_abnormal_cartilage_morphology | 0.67734558 |
| 136 | MP0000049_abnormal_middle_ear | 0.67168519 |
| 137 | MP0002090_abnormal_vision | 0.66476293 |
| 138 | MP0005187_abnormal_penis_morphology | 0.66129603 |
| 139 | MP0000762_abnormal_tongue_morphology | 0.65548286 |
| 140 | MP0002734_abnormal_mechanical_nocicepti | 0.64944584 |
| 141 | MP0003045_fibrosis | 0.64615136 |
| 142 | MP0005195_abnormal_posterior_eye | 0.63341497 |
| 143 | MP0003221_abnormal_cardiomyocyte_apopto | 0.61104488 |
| 144 | MP0002184_abnormal_innervation | 0.61014763 |
| 145 | MP0000462_abnormal_digestive_system | 0.61005052 |
| 146 | MP0002752_abnormal_somatic_nervous | 0.60727205 |
| 147 | MP0003942_abnormal_urinary_system | 0.60279336 |
| 148 | MP0002063_abnormal_learning/memory/cond | 0.60272227 |
| 149 | MP0000230_abnormal_systemic_arterial | 0.60140651 |
| 150 | MP0002064_seizures | 0.59170510 |
| 151 | MP0000920_abnormal_myelination | 0.57804949 |
| 152 | MP0002067_abnormal_sensory_capabilities | 0.57669551 |
| 153 | MP0003935_abnormal_craniofacial_develop | 0.57466823 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Exercise-induced myalgia (HP:0003738) | 5.77403819 |
| 2 | Muscle hypertrophy of the lower extremities (HP:0008968) | 5.32829566 |
| 3 | Calf muscle hypertrophy (HP:0008981) | 5.17342404 |
| 4 | Muscle fiber splitting (HP:0003555) | 5.13676727 |
| 5 | Exercise-induced muscle cramps (HP:0003710) | 4.96563625 |
| 6 | Sudden death (HP:0001699) | 4.76155352 |
| 7 | Muscle fiber inclusion bodies (HP:0100299) | 4.69161953 |
| 8 | Hyporeflexia of lower limbs (HP:0002600) | 4.67442416 |
| 9 | Type 1 muscle fiber predominance (HP:0003803) | 4.66090708 |
| 10 | Difficulty running (HP:0009046) | 4.60936953 |
| 11 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.59159467 |
| 12 | Abnormality of the calf musculature (HP:0001430) | 4.36647914 |
| 13 | Protrusio acetabuli (HP:0003179) | 4.27394103 |
| 14 | Increased connective tissue (HP:0009025) | 4.13361655 |
| 15 | Nemaline bodies (HP:0003798) | 4.01334452 |
| 16 | EMG: myopathic abnormalities (HP:0003458) | 3.93534940 |
| 17 | Increased variability in muscle fiber diameter (HP:0003557) | 3.89639047 |
| 18 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.68740147 |
| 19 | Myotonia (HP:0002486) | 3.67780438 |
| 20 | Ventricular tachycardia (HP:0004756) | 3.54243629 |
| 21 | Myoglobinuria (HP:0002913) | 3.50299946 |
| 22 | Subaortic stenosis (HP:0001682) | 3.46415145 |
| 23 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.46415145 |
| 24 | Atrial fibrillation (HP:0005110) | 3.35031443 |
| 25 | Round ear (HP:0100830) | 3.24032660 |
| 26 | Prolonged QT interval (HP:0001657) | 3.14180427 |
| 27 | Primary atrial arrhythmia (HP:0001692) | 3.13934003 |
| 28 | Obstructive sleep apnea (HP:0002870) | 3.05866477 |
| 29 | Central scotoma (HP:0000603) | 3.04310017 |
| 30 | Distal arthrogryposis (HP:0005684) | 2.96066948 |
| 31 | Supraventricular tachycardia (HP:0004755) | 2.95251580 |
| 32 | Difficulty climbing stairs (HP:0003551) | 2.94344847 |
| 33 | Supraventricular arrhythmia (HP:0005115) | 2.93267177 |
| 34 | Cervical subluxation (HP:0003308) | 2.92394741 |
| 35 | Myopathic facies (HP:0002058) | 2.91403237 |
| 36 | Bundle branch block (HP:0011710) | 2.91373145 |
| 37 | Hyperacusis (HP:0010780) | 2.88595217 |
| 38 | Muscle stiffness (HP:0003552) | 2.82861286 |
| 39 | Lipoatrophy (HP:0100578) | 2.81884168 |
| 40 | Vascular tortuosity (HP:0004948) | 2.78028193 |
| 41 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.77497478 |
| 42 | Nuclear cataract (HP:0100018) | 2.77480413 |
| 43 | Broad metatarsal (HP:0001783) | 2.74850234 |
| 44 | Asymmetric septal hypertrophy (HP:0001670) | 2.73986042 |
| 45 | Arterial tortuosity (HP:0005116) | 2.73050319 |
| 46 | Vertebral compression fractures (HP:0002953) | 2.72953716 |
| 47 | Scapular winging (HP:0003691) | 2.65699704 |
| 48 | Fragile skin (HP:0001030) | 2.60872355 |
| 49 | Broad face (HP:0000283) | 2.58527511 |
| 50 | Right ventricular cardiomyopathy (HP:0011663) | 2.56121415 |
| 51 | Upper limb amyotrophy (HP:0009129) | 2.55293163 |
| 52 | Distal upper limb amyotrophy (HP:0007149) | 2.55293163 |
| 53 | Syncope (HP:0001279) | 2.50569088 |
| 54 | Ulnar bowing (HP:0003031) | 2.50249014 |
| 55 | Stridor (HP:0010307) | 2.49368466 |
| 56 | Short nail (HP:0001799) | 2.48303754 |
| 57 | Neck muscle weakness (HP:0000467) | 2.47984780 |
| 58 | Hypoplastic ischia (HP:0003175) | 2.41354441 |
| 59 | Mitral regurgitation (HP:0001653) | 2.40060992 |
| 60 | Spinal rigidity (HP:0003306) | 2.39606384 |
| 61 | Atrophic scars (HP:0001075) | 2.39241377 |
| 62 | Rimmed vacuoles (HP:0003805) | 2.37002573 |
| 63 | Dilated cardiomyopathy (HP:0001644) | 2.35552733 |
| 64 | Neurofibrillary tangles (HP:0002185) | 2.34795738 |
| 65 | Achilles tendon contracture (HP:0001771) | 2.34410076 |
| 66 | Limb-girdle muscle atrophy (HP:0003797) | 2.32417191 |
| 67 | Aortic dissection (HP:0002647) | 2.31664678 |
| 68 | Ventricular fibrillation (HP:0001663) | 2.29440678 |
| 69 | Aortic aneurysm (HP:0004942) | 2.25956623 |
| 70 | Gowers sign (HP:0003391) | 2.25709375 |
| 71 | Ventricular arrhythmia (HP:0004308) | 2.24035813 |
| 72 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.22779217 |
| 73 | Distal lower limb amyotrophy (HP:0008944) | 2.22575494 |
| 74 | Abnormal EKG (HP:0003115) | 2.22567064 |
| 75 | Abnormality of glycolipid metabolism (HP:0010969) | 2.22142380 |
| 76 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.22142380 |
| 77 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.22142380 |
| 78 | Ankle contracture (HP:0006466) | 2.20038380 |
| 79 | Calcaneovalgus deformity (HP:0001848) | 2.19112003 |
| 80 | Thin bony cortex (HP:0002753) | 2.17454772 |
| 81 | Abnormality of the nasal mucosa (HP:0000433) | 2.17194438 |
| 82 | Abnormality of dentin (HP:0010299) | 2.16174941 |
| 83 | Scotoma (HP:0000575) | 2.15552703 |
| 84 | Flat acetabular roof (HP:0003180) | 2.14807788 |
| 85 | Ulnar deviation of the wrist (HP:0003049) | 2.13969243 |
| 86 | Dysostosis multiplex (HP:0000943) | 2.12788921 |
| 87 | Heart block (HP:0012722) | 2.12426928 |
| 88 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.12071401 |
| 89 | Rhabdomyolysis (HP:0003201) | 2.11912648 |
| 90 | Lower limb amyotrophy (HP:0007210) | 2.11438403 |
| 91 | Axonal loss (HP:0003447) | 2.10444564 |
| 92 | Abnormality of the ischium (HP:0003174) | 2.08104872 |
| 93 | Limb-girdle muscle weakness (HP:0003325) | 2.08069435 |
| 94 | Nasal polyposis (HP:0100582) | 2.07787931 |
| 95 | Slender build (HP:0001533) | 2.07401931 |
| 96 | Proximal amyotrophy (HP:0007126) | 2.07032972 |
| 97 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.06917383 |
| 98 | Abnormal atrioventricular conduction (HP:0005150) | 2.06877760 |
| 99 | Blue sclerae (HP:0000592) | 2.05695495 |
| 100 | Bulbar palsy (HP:0001283) | 2.05448323 |
| 101 | Muscular dystrophy (HP:0003560) | 2.05139943 |
| 102 | Generalized amyotrophy (HP:0003700) | 2.04934911 |
| 103 | Abnormality of the Achilles tendon (HP:0005109) | 2.04351663 |
| 104 | Cerebral inclusion bodies (HP:0100314) | 2.04007771 |
| 105 | Atelectasis (HP:0100750) | 2.03431439 |
| 106 | Aneurysm (HP:0002617) | 2.01186522 |
| 107 | Joint stiffness (HP:0001387) | 2.01005316 |
| 108 | Absent phalangeal crease (HP:0006109) | 1.99495816 |
| 109 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.99301919 |
| 110 | Deformed tarsal bones (HP:0008119) | 1.98367625 |
| 111 | Abnormality of the foot musculature (HP:0001436) | 1.96907166 |
| 112 | Mucopolysacchariduria (HP:0008155) | 1.96741175 |
| 113 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.96741175 |
| 114 | EMG: neuropathic changes (HP:0003445) | 1.95786057 |
| 115 | Genu recurvatum (HP:0002816) | 1.95475649 |
| 116 | Left ventricular hypertrophy (HP:0001712) | 1.94824041 |
| 117 | Foot dorsiflexor weakness (HP:0009027) | 1.93861603 |
| 118 | Turricephaly (HP:0000262) | 1.93544385 |
| 119 | Interstitial pulmonary disease (HP:0006530) | 1.93475047 |
| 120 | Shallow orbits (HP:0000586) | 1.92812938 |
| 121 | Wormian bones (HP:0002645) | 1.91508947 |
| 122 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.91158514 |
| 123 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.91158514 |
| 124 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.91158514 |
| 125 | Distal lower limb muscle weakness (HP:0009053) | 1.90557761 |
| 126 | Long toe (HP:0010511) | 1.88043522 |
| 127 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.86815715 |
| 128 | Dilatation of the ascending aorta (HP:0005111) | 1.86296563 |
| 129 | Hand muscle atrophy (HP:0009130) | 1.83978700 |
| 130 | Pheochromocytoma (HP:0002666) | 1.83639180 |
| 131 | Premature rupture of membranes (HP:0001788) | 1.81758260 |
| 132 | Absent frontal sinuses (HP:0002688) | 1.81465311 |
| 133 | Neonatal short-limb short stature (HP:0008921) | 1.81442540 |
| 134 | Aortic regurgitation (HP:0001659) | 1.79826920 |
| 135 | Spinal cord compression (HP:0002176) | 1.78359524 |
| 136 | Biconcave vertebral bodies (HP:0004586) | 1.77020741 |
| 137 | Large for gestational age (HP:0001520) | 1.76495213 |
| 138 | Osteolytic defects of the hand bones (HP:0009699) | 1.75897890 |
| 139 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.75897890 |
| 140 | Hip contracture (HP:0003273) | 1.75358910 |
| 141 | Mitral stenosis (HP:0001718) | 1.74730698 |
| 142 | Elbow flexion contracture (HP:0002987) | 1.73870318 |
| 143 | Shoulder girdle muscle weakness (HP:0003547) | 1.73522185 |
| 144 | Atrioventricular block (HP:0001678) | 1.73377122 |
| 145 | Frequent falls (HP:0002359) | 1.73359627 |
| 146 | Palpitations (HP:0001962) | 1.73340163 |
| 147 | Congenital glaucoma (HP:0001087) | 1.72720143 |
| 148 | Coxa vara (HP:0002812) | 1.71277243 |
| 149 | Rapidly progressive (HP:0003678) | 1.71239802 |
| 150 | Termporal pattern (HP:0011008) | 1.69573584 |
| 151 | Insidious onset (HP:0003587) | 1.69573584 |
| 152 | Hyperkalemia (HP:0002153) | 1.67991507 |
| 153 | Generalized muscle weakness (HP:0003324) | 1.63676514 |
| 154 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.63361892 |
| 155 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.63361892 |
| 156 | Bladder diverticulum (HP:0000015) | 1.62929108 |
| 157 | Facial diplegia (HP:0001349) | 1.61933592 |
| 158 | Abnormal finger flexion creases (HP:0006143) | 1.61123622 |
| 159 | Neuroendocrine neoplasm (HP:0100634) | 1.55386127 |
| 160 | Areflexia of lower limbs (HP:0002522) | 1.53450328 |
| 161 | Cerebral aneurysm (HP:0004944) | 1.52884042 |
| 162 | Dysmetric saccades (HP:0000641) | 1.52592348 |
| 163 | Bronchomalacia (HP:0002780) | 1.51545803 |
| 164 | Bell-shaped thorax (HP:0001591) | 1.50181424 |
| 165 | Buphthalmos (HP:0000557) | 1.49674356 |
| 166 | Pelvic girdle muscle weakness (HP:0003749) | 1.49512437 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 4.85141264 |
| 2 | PHKG2 | 4.21703174 |
| 3 | PHKG1 | 4.21703174 |
| 4 | OBSCN | 3.61416935 |
| 5 | EPHA2 | 3.56905599 |
| 6 | TRIB3 | 3.04595466 |
| 7 | DMPK | 2.71110931 |
| 8 | ERN1 | 2.43942556 |
| 9 | MST1R | 2.28944863 |
| 10 | TESK1 | 2.21395768 |
| 11 | LMTK2 | 2.14782756 |
| 12 | IRAK3 | 2.07854478 |
| 13 | MARK1 | 1.73813122 |
| 14 | EPHB2 | 1.73413798 |
| 15 | PIK3CA | 1.70976561 |
| 16 | PDGFRA | 1.67363181 |
| 17 | SMG1 | 1.65729358 |
| 18 | PKN2 | 1.62311832 |
| 19 | INSRR | 1.58116601 |
| 20 | MYLK | 1.57149731 |
| 21 | MAP2K3 | 1.55930163 |
| 22 | PAK4 | 1.49933767 |
| 23 | MUSK | 1.48922613 |
| 24 | MAP3K3 | 1.48834025 |
| 25 | PAK3 | 1.38931387 |
| 26 | MET | 1.38858561 |
| 27 | MAP3K7 | 1.38679182 |
| 28 | WNK4 | 1.38413969 |
| 29 | SIK1 | 1.35864955 |
| 30 | EPHB1 | 1.34911603 |
| 31 | PRPF4B | 1.33292144 |
| 32 | RIPK1 | 1.30726427 |
| 33 | CAMK1G | 1.28051820 |
| 34 | PAK6 | 1.26571464 |
| 35 | DDR2 | 1.26549683 |
| 36 | PINK1 | 1.24978125 |
| 37 | PRKD1 | 1.23791730 |
| 38 | PKN1 | 1.21786336 |
| 39 | UHMK1 | 1.18156754 |
| 40 | ILK | 1.16741562 |
| 41 | STK39 | 1.14118934 |
| 42 | ICK | 1.13989646 |
| 43 | NME2 | 1.13696260 |
| 44 | MAPKAPK3 | 1.12631098 |
| 45 | NTRK1 | 1.08981886 |
| 46 | WNK1 | 1.06733002 |
| 47 | PRKD3 | 1.05635912 |
| 48 | NME1 | 1.04959749 |
| 49 | TIE1 | 1.04645778 |
| 50 | NTRK2 | 1.02904550 |
| 51 | ROCK1 | 1.02050839 |
| 52 | FGFR4 | 1.00557404 |
| 53 | MOS | 1.00403015 |
| 54 | CDC42BPA | 0.99113314 |
| 55 | ROCK2 | 0.95201912 |
| 56 | FGFR2 | 0.93080886 |
| 57 | CAMK2D | 0.92934329 |
| 58 | MARK2 | 0.92283358 |
| 59 | TAOK2 | 0.89886088 |
| 60 | PTK6 | 0.88892572 |
| 61 | MAPK12 | 0.88644488 |
| 62 | LATS2 | 0.87957729 |
| 63 | TBK1 | 0.84444719 |
| 64 | PDK3 | 0.83878080 |
| 65 | PDK4 | 0.83878080 |
| 66 | PIK3CG | 0.83018940 |
| 67 | KSR2 | 0.81864922 |
| 68 | MAP3K11 | 0.78587238 |
| 69 | MAP3K6 | 0.78287630 |
| 70 | ARAF | 0.77114648 |
| 71 | FER | 0.77026895 |
| 72 | PRKCH | 0.76370179 |
| 73 | MAP3K4 | 0.76175064 |
| 74 | SGK223 | 0.73501903 |
| 75 | SGK494 | 0.73501903 |
| 76 | RET | 0.73408124 |
| 77 | TGFBR2 | 0.73315292 |
| 78 | ABL2 | 0.72565117 |
| 79 | HIPK2 | 0.71898268 |
| 80 | STK38 | 0.70199321 |
| 81 | LIMK1 | 0.69184997 |
| 82 | CAMK1D | 0.68793103 |
| 83 | PRKAA1 | 0.68402343 |
| 84 | PAK2 | 0.68242490 |
| 85 | BMX | 0.66960377 |
| 86 | LRRK2 | 0.66689300 |
| 87 | PRKD2 | 0.66535339 |
| 88 | MAP3K13 | 0.65830828 |
| 89 | NEK1 | 0.65350536 |
| 90 | MAP3K1 | 0.64437643 |
| 91 | RPS6KA2 | 0.63641213 |
| 92 | TYRO3 | 0.63544527 |
| 93 | MTOR | 0.62360176 |
| 94 | PRKAA2 | 0.61755770 |
| 95 | IRAK2 | 0.61310325 |
| 96 | MAPK15 | 0.61049940 |
| 97 | PDGFRB | 0.59388246 |
| 98 | DAPK3 | 0.58227693 |
| 99 | PTK2 | 0.57485663 |
| 100 | CDK12 | 0.57314213 |
| 101 | RPS6KC1 | 0.56861783 |
| 102 | RPS6KL1 | 0.56861783 |
| 103 | MAP2K4 | 0.56144384 |
| 104 | ZAP70 | 0.56109604 |
| 105 | NEK9 | 0.54561115 |
| 106 | BCKDK | 0.54355709 |
| 107 | CAMK2A | 0.53936267 |
| 108 | CDK5 | 0.53894719 |
| 109 | PRKG2 | 0.52491560 |
| 110 | TRPM7 | 0.51396652 |
| 111 | CAMK4 | 0.50889353 |
| 112 | PRKCE | 0.50820534 |
| 113 | MAPKAPK5 | 0.50690638 |
| 114 | DYRK1B | 0.50166984 |
| 115 | CAMK2B | 0.49249272 |
| 116 | EEF2K | 0.49202121 |
| 117 | STK11 | 0.48385370 |
| 118 | ERBB2 | 0.48089386 |
| 119 | CAMK1 | 0.47640980 |
| 120 | CSK | 0.45037667 |
| 121 | MAPK13 | 0.44237197 |
| 122 | PRKACB | 0.44103460 |
| 123 | LATS1 | 0.42594034 |
| 124 | NTRK3 | 0.42483047 |
| 125 | CAMK2G | 0.42459024 |
| 126 | CAMKK1 | 0.41996293 |
| 127 | MAP2K2 | 0.41355013 |
| 128 | TNIK | 0.40993918 |
| 129 | PRKG1 | 0.40740716 |
| 130 | MAP3K2 | 0.40633175 |
| 131 | PNCK | 0.40583010 |
| 132 | EPHA3 | 0.40219429 |
| 133 | SGK1 | 0.40104238 |
| 134 | SGK3 | 0.39267392 |
| 135 | RPS6KA3 | 0.38012595 |
| 136 | PDPK1 | 0.37886020 |
| 137 | MAP2K1 | 0.37635115 |
| 138 | TAOK1 | 0.37146792 |
| 139 | RPS6KA6 | 0.35741196 |
| 140 | MAPKAPK2 | 0.34502543 |
| 141 | ERBB4 | 0.34445523 |
| 142 | SIK2 | 0.33975259 |
| 143 | MAP2K6 | 0.32281182 |
| 144 | MAPK7 | 0.31180326 |
| 145 | PTK2B | 0.30980136 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.09608446 |
| 2 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.92964597 |
| 3 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.61974278 |
| 4 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.59173970 |
| 5 | Other glycan degradation_Homo sapiens_hsa00511 | 2.39426348 |
| 6 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.17142690 |
| 7 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.12694832 |
| 8 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 2.02612827 |
| 9 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.02237738 |
| 10 | Phototransduction_Homo sapiens_hsa04744 | 1.75740163 |
| 11 | Insulin secretion_Homo sapiens_hsa04911 | 1.57241029 |
| 12 | Circadian entrainment_Homo sapiens_hsa04713 | 1.48912283 |
| 13 | Lysosome_Homo sapiens_hsa04142 | 1.48830466 |
| 14 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.47293276 |
| 15 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.46957568 |
| 16 | Prion diseases_Homo sapiens_hsa05020 | 1.45974031 |
| 17 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.44702262 |
| 18 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.43982343 |
| 19 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.39860898 |
| 20 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.39381011 |
| 21 | Bladder cancer_Homo sapiens_hsa05219 | 1.38765096 |
| 22 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.37296169 |
| 23 | Focal adhesion_Homo sapiens_hsa04510 | 1.35846382 |
| 24 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.34039530 |
| 25 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.29378813 |
| 26 | Renin secretion_Homo sapiens_hsa04924 | 1.29151454 |
| 27 | GABAergic synapse_Homo sapiens_hsa04727 | 1.28681780 |
| 28 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.28281133 |
| 29 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.28076675 |
| 30 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.27447401 |
| 31 | Axon guidance_Homo sapiens_hsa04360 | 1.25845552 |
| 32 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.24593994 |
| 33 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.24429904 |
| 34 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.23113806 |
| 35 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.22122000 |
| 36 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.16018242 |
| 37 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.15756231 |
| 38 | Tight junction_Homo sapiens_hsa04530 | 1.15368620 |
| 39 | Insulin resistance_Homo sapiens_hsa04931 | 1.10911068 |
| 40 | Gap junction_Homo sapiens_hsa04540 | 1.09910795 |
| 41 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.09802424 |
| 42 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.09326040 |
| 43 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.09096046 |
| 44 | Melanogenesis_Homo sapiens_hsa04916 | 1.08549441 |
| 45 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.08092439 |
| 46 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.07518027 |
| 47 | Viral myocarditis_Homo sapiens_hsa05416 | 1.07321180 |
| 48 | Morphine addiction_Homo sapiens_hsa05032 | 1.05796387 |
| 49 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.04796297 |
| 50 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.03272974 |
| 51 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.02883972 |
| 52 | Salivary secretion_Homo sapiens_hsa04970 | 1.01615465 |
| 53 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.01121252 |
| 54 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.00739027 |
| 55 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.00443277 |
| 56 | Alzheimers disease_Homo sapiens_hsa05010 | 0.99485944 |
| 57 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.99343904 |
| 58 | Cocaine addiction_Homo sapiens_hsa05030 | 0.98836707 |
| 59 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.98717073 |
| 60 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.98563468 |
| 61 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.97224803 |
| 62 | Endocytosis_Homo sapiens_hsa04144 | 0.97002129 |
| 63 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.96956627 |
| 64 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.95009934 |
| 65 | Salmonella infection_Homo sapiens_hsa05132 | 0.94877698 |
| 66 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.93792337 |
| 67 | Hepatitis C_Homo sapiens_hsa05160 | 0.93778418 |
| 68 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.92706166 |
| 69 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.92138775 |
| 70 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.91269093 |
| 71 | Parkinsons disease_Homo sapiens_hsa05012 | 0.90271162 |
| 72 | Galactose metabolism_Homo sapiens_hsa00052 | 0.90018358 |
| 73 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.89873242 |
| 74 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.89239975 |
| 75 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.89184065 |
| 76 | Taste transduction_Homo sapiens_hsa04742 | 0.88540173 |
| 77 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.85895379 |
| 78 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.85490738 |
| 79 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.85270773 |
| 80 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.85174008 |
| 81 | Circadian rhythm_Homo sapiens_hsa04710 | 0.84900095 |
| 82 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.84861656 |
| 83 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.84370967 |
| 84 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.84028498 |
| 85 | Olfactory transduction_Homo sapiens_hsa04740 | 0.84002136 |
| 86 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.83457660 |
| 87 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.82839930 |
| 88 | Long-term potentiation_Homo sapiens_hsa04720 | 0.82563951 |
| 89 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.82552694 |
| 90 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.81744409 |
| 91 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.80657414 |
| 92 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.78711951 |
| 93 | Long-term depression_Homo sapiens_hsa04730 | 0.78462089 |
| 94 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.78170099 |
| 95 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.77032742 |
| 96 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.76516177 |
| 97 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.76314563 |
| 98 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.75000554 |
| 99 | Glioma_Homo sapiens_hsa05214 | 0.74122062 |
| 100 | Amoebiasis_Homo sapiens_hsa05146 | 0.73119375 |
| 101 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.73048770 |
| 102 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.72964193 |
| 103 | Thyroid cancer_Homo sapiens_hsa05216 | 0.70759068 |
| 104 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.70703799 |
| 105 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.69359013 |
| 106 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.68822382 |
| 107 | Malaria_Homo sapiens_hsa05144 | 0.68790942 |
| 108 | Pertussis_Homo sapiens_hsa05133 | 0.68023899 |
| 109 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.67522186 |
| 110 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.66979121 |
| 111 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.66958783 |
| 112 | Prostate cancer_Homo sapiens_hsa05215 | 0.66178040 |
| 113 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.65875614 |
| 114 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.65151851 |
| 115 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.64666731 |
| 116 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.64126531 |
| 117 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.64060967 |
| 118 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.64052684 |
| 119 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.62794126 |
| 120 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.62560391 |
| 121 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.62397471 |
| 122 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.61540960 |
| 123 | Adherens junction_Homo sapiens_hsa04520 | 0.60894899 |
| 124 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.60241872 |
| 125 | Shigellosis_Homo sapiens_hsa05131 | 0.59877709 |
| 126 | Nicotine addiction_Homo sapiens_hsa05033 | 0.59209988 |
| 127 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.58649536 |
| 128 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.58401736 |
| 129 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.56934175 |
| 130 | Endometrial cancer_Homo sapiens_hsa05213 | 0.56446764 |
| 131 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.56349336 |
| 132 | Pathways in cancer_Homo sapiens_hsa05200 | 0.56253764 |
| 133 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.56106306 |
| 134 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.55699014 |
| 135 | Lysine degradation_Homo sapiens_hsa00310 | 0.54613110 |
| 136 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.54179049 |
| 137 | Phagosome_Homo sapiens_hsa04145 | 0.54078152 |
| 138 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.53859677 |
| 139 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.52777531 |
| 140 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.52591394 |
| 141 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.52378510 |
| 142 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.50880411 |
| 143 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.50519195 |
| 144 | Apoptosis_Homo sapiens_hsa04210 | 0.50455253 |
| 145 | Tuberculosis_Homo sapiens_hsa05152 | 0.50421489 |
| 146 | Histidine metabolism_Homo sapiens_hsa00340 | 0.50223176 |
| 147 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.50068337 |
| 148 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.49776587 |
| 149 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.49284999 |

